Annexon Stock Analysis

Annexon Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.03. Some equities with similar Price to Book (P/B) outperform the market in the long run. Annexon recorded a loss per share of 1.01. The entity had not issued any dividends in recent years. Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company was incorporated in 2011 and is headquartered in Brisbane, California. Annexon operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people. For more info on Annexon please contact JD Esq at 650 822 5500 or go to https://www.annexonbio.com.

Annexon Investment Alerts

Annexon Upcoming and Recent Events

Annexon Largest EPS Surprises

View All Earnings Estimates

Annexon Environmental, Social, and Governance (ESG) Scores

Annexon Stock Institutional Investors

Note, although Annexon's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Annexon Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 274.28 M.

Annexon Profitablity

Management Efficiency

Annexon has return on total asset (ROA) of (0.2973) % which means that it has lost $0.2973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5084) %, meaning that it created substantial loss on money invested by shareholders. Annexon's management efficiency ratios could be used to measure how well Annexon manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.41 in 2025. Return On Capital Employed is likely to drop to -0.51 in 2025. At this time, Annexon's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 4.5 M in 2025, whereas Total Assets are likely to drop slightly above 231.2 M in 2025.

Technical Drivers

As of the 19th of March, Annexon shows the Mean Deviation of 3.61, standard deviation of 4.84, and Risk Adjusted Performance of (0.15). Annexon technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Annexon Price Movement Analysis

Annexon Insider Trading Activities

Annexon Outstanding Bonds

Annexon Predictive Daily Indicators

Annexon Corporate Filings

Annexon Forecast Models

Annexon's time-series forecasting models are one of many Annexon's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Annexon's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Annexon prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Annexon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Annexon. By using and applying Annexon Stock analysis, traders can create a robust methodology for identifying Annexon entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Annexon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Annexon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Annexon stock analysis indicators help investors evaluate how Annexon stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Annexon shares will generate the highest return on investment. By understating and applying Annexon stock analysis, traders can identify Annexon position entry and exit signals to maximize returns.

When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.